ZOLA P. HOROVITZ, PH.D. - Corporate Board Profile

PALATIN TECHNOLOGIES INC

Filing Date	Source Excerpt
2001-10-26	Zola P. Horovitz, Ph.D. has been a director since February 2001... The compensation committee is composed of Mr. Flannery, Dr. Prendergast, Mr. deVeer and Dr. Horovitz.
2002-10-28	Zola P. Horovitz, Ph.D. has been a director since February 2001. Before he retired from Bristol-Myers Squibb in 1994, Dr. Horovitz spent 34 years in various positions, including associate director of the Squibb Institute for Medical Research, vice president of development, vice president, scientific liaison, vice president of licensing, and vice president of business development and planning, for the pharmaceutical division of Bristol-Myers Squibb. He held advisory positions at the University of Pittsburgh, Rutgers College of Pharmacy and Princeton University. He is currently a director of seven other publicly held companies: Genaera Corporation, Biocryst Pharmaceuticals, Diacrin, Avigen, Synaptic Pharmaceutical, 3-Dimensional Pharmaceuticals and Dov Pharmaceuticals; and four non-public companies: Phyton, Epigenesis, Immunicon and Nitromed. Dr. Horovitz earned his Ph.D. in Pharmacology from the University of Pittsburgh. Zola P. Horovitz, Ph.D., director. He is a member of the compensation committee.
2003-11-14	Zola P. Horovitz, Ph.D. has been a director since February 2001... He is a member of the audit committee, compensation committee, and nominating and corporate governance committee.
2004-07-29	During the fiscal year ended June 30, 2004, Dr. Horovitz served on the compensation committee.
2004-10-28	Zola P. Horovitz, Ph.D. has been a director since February 2001. Before he retired from Bristol-Myers Squibb in 1994, Dr. Horovitz spent 34 years in various positions.
2005-05-04	Dr. Horovitz served on the compensation committee during fiscal year ended June 30, 2004.
2005-10-28	Zola P. Horovitz, Ph.D. has been a director since February 2001. Before he retired from Bristol-Myers Squibb in 1994, Dr. Horovitz spent 34 years in various positions, including associate director of the Squibb Institute for Medical Research, vice president of development, vice president, scientific liaison, vice president of licensing, and vice president of business development and planning, for the pharmaceutical division of Bristol-Myers Squibb. He held advisory positions at the University of Pittsburgh, Rutgers College of Pharmacy and Princeton University. He is also currently a director of the following publicly-held companies: Genaera Corporation, Biocryst Pharmaceuticals, Inc., Avigen, Inc., Dov Pharmaceutical, Inc., NitroMed, Inc., GenVec, Inc. and Immunicon Corporation. Dr. Horovitz earned his Ph.D. in Pharmacology from the University of Pittsburgh.
2006-10-30	Zola P. Horovitz, Ph.D. has been a director since February 2001. Before he retired from Bristol-Myers Squibb in 1994, Dr. Horovitz spent 34 years in various positions, including associate director of the Squibb Institute for Medical Research, vice president of development, vice president, scientific liaison, vice president of licensing, and vice president of business development and planning for the pharmaceutical division of Bristol-Myers Squibb. He is a member of the audit committee, compensation committee and nominating and corporate governance committee.
2007-10-29	Zola P. Horovitz, Ph.D. has been a director since February 2001. Before he retired from Bristol-Myers Squibb in 1994, Dr. Horovitz spent 34 years in various positions, including associate director of the Squibb Institute for Medical Research, vice president of development, vice president, scientific liaison, vice president of licensing, and vice president of business development and planning for the pharmaceutical division of Bristol-Myers Squibb.
2009-03-31	Zola P. Horovitz, Ph.D. has been a director since February 2001. He is a member of the audit committee, compensation committee and nominating and corporate governance committee.
2010-04-07	Zola P. Horovitz, Ph.D. has been a director since February 2001. Before he retired from Bristol-Myers Squibb in 1994, Dr. Horovitz spent 34 years in various positions, including associate director of the Squibb Institute for Medical Research, vice president of development, vice president, scientific liaison, vice president of licensing, and vice president of business development and planning for the pharmaceutical division of Bristol-Myers Squibb. He held advisory positions at the University of Pittsburgh, Rutgers College of Pharmacy and Princeton University. He is also currently a director of the following publicly-held life science companies: BioCryst Pharmaceuticals, Inc., DOV Pharmaceutical, Inc. and GenVec, Inc. Dr. Horovitz earned his Ph.D. in pharmacology from the University of Pittsburgh. He is a member of the audit committee, compensation committee and nominating and corporate governance committee.
2011-04-05	Zola P. Horovitz, Ph.D. has been a director since February 2001. ... (1)Member of the Audit Committee. (2) Member of the Compensation Committee. (3) Member of the Nominating and Corporate Governance Committee. ... The Audit Committee is composed of three non-employee directors, Mr. deVeer, Dr. Horovitz and Dr. Taber. ... The Compensation Committee is composed of Mr. deVeer, Dr. Horovitz and Dr. Taber. ... The Nominating and Corporate Governance Committee is composed of Mr. deVeer and Dr. Horovitz.
2012-04-20	Zola P. Horovitz, Ph.D., has been a director since February 2001... Member of the Compensation Committee and Nominating and Corporate Governance Committee. Total compensation: $91,822.
2012-07-31	Zola P. Horovitz, Ph.D. listed as a director in the beneficial ownership table
2013-05-15	Zola P. Horovitz, Ph.D. has been a director since February 2001. He is a member of the compensation committee and the nominating and corporate governance committee. For our 2012 fiscal year, Dr. Horovitz received an annual retainer of $37,500.
2014-05-06	Zola P. Horovitz, Ph.D. has been a director since February 2001... Member of the compensation committee and nominating and corporate governance committee... Director compensation table shows total compensation of $63,464.
2015-04-24	Zola P. Horovitz, Ph.D. has been a director since February 2001. ... Dr. Horovitz has extensive experience in development of pharmaceutical drugs, business development and licensing, and has served on the board of directors of a number of publicly-held life science companies.